Last reviewed · How we verify

NCT07034911

Ketamine vs Ephedrine on Post Spinal Hypotension in Caesarean Delivery

Completed Phase 1 Last updated 24 June 2025
What this trial tests

Phase 1 trial testing Ketalar in Post Spinal Hypotension in 100 participants. Completed in 15 September 2024.

Timeline
1 April 2024
Primary endpoint
1 September 2024
15 September 2024

Quick facts

Lead sponsorAin Shams University
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment100
Start date1 April 2024
Primary completion1 September 2024
Estimated completion15 September 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 45, female only, with Post Spinal Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparing ketamine and ephedrine to decrease the incidence of post spinal hypotension after caesarean section delivery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ketalar

Trials testing the same drug.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07034911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing